Key Takeaways

A pill already on the market might help slow progression of type 1 diabetes

Baricitinib taken daily preserved people’s insulin production and stabilized their blood sugar

The pill is already approved for autoimmune disorders like rheumatoid arthritis and alopecia

TUESDAY, Sept. 23, 2025 (HealthDay News) — A pill typically prescribed for rheumatoid arthritis and alopecia might help slow the progression of type 1 diabetes , a new study says.

Baricitinib safely preserved the body’s own insulin production in people newly diagnosed with type 1 diabetes, researchers reported Friday at the annual meeting of the European Association for the Study of Diabetes in Vienna.

Further, patients’ diabetes started progressing once they stopped taking baricitinib, results show. They pr

See Full Page